{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:57:19Z","timestamp":1788195439877,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neuropharm.2020.108303","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T11:21:43Z","timestamp":1599650503000},"page":"108303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis"],"prefix":"10.1016","volume":"182","author":[{"given":"Natalie K.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108303_bib1","article-title":"Notes sur la curarine et ses effets physiologiques","author":"Bernard","year":"1856","journal-title":"Bulletin General Therapeutique"},{"key":"10.1016\/j.neuropharm.2020.108303_bib2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/pan.12152","article-title":"From arrow poison to neuromuscular blockade","volume":"23","author":"Brown","year":"2013","journal-title":"Pediatric Anesthesia"},{"key":"10.1016\/j.neuropharm.2020.108303_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1113\/jphysiol.1934.sp003166","article-title":"The chemical transmitter of vagus effects to the stomach","volume":"82","author":"Dale","year":"1934","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108303_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(25)07356-9","article-title":"The beginnings and the prospects of neurohumoral transmission","volume":"6","author":"Dale","year":"1954","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108303_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2020.108303_bib6","series-title":"Minds behind the Brain: A History of the Pioneers and Their Discoveries","first-page":"259","article-title":"Otto Loewi and Henry Dale: the discovery of neurotransmitters","author":"Finger","year":"2000"},{"key":"10.1016\/j.neuropharm.2020.108303_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis. Classification, clinical presentation, natural history and epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2020.108303_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis task force of the medical scientific advisory board of the MGFA recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2020.108303_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02569052","article-title":"Mary B Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis","volume":"93","author":"Keeney","year":"1997","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.neuropharm.2020.108303_bib10","series-title":"Myasthenia Gravis: an Illustrated History","author":"Keesey","year":"2002"},{"key":"10.1016\/j.neuropharm.2020.108303_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01738910","article-title":"\u00dcber humorale \u00dcbertragbarkeit der Herznervenwirkung","volume":"189","author":"Loewi","year":"1921","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2020.108303_bib12","series-title":"Miller's Anesthesia","first-page":"832","article-title":"Reversal (antagonism) of neuromuscular blockade","author":"Murphy","year":"2020"},{"key":"10.1016\/j.neuropharm.2020.108303_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1954.03690290011004","article-title":"Studies in myasthenia gravis. Preliminary report on therapy with Mestinon bromide","volume":"155","author":"Osserman","year":"1954","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2020.108303_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000187743","article-title":"\u00dceber den motorischen Einfluss des Splanchnicus auf der D\u00fcnndarm","volume":"5","author":"Pal","year":"1899","journal-title":"Arch Verdauungskrankheiten"},{"key":"10.1016\/j.neuropharm.2020.108303_bib15","first-page":"255","article-title":"Physostigmin ein Gegengift des Curarae","volume":"10","author":"Pal","year":"1900","journal-title":"Zent. bl Physiol."},{"key":"10.1016\/j.neuropharm.2020.108303_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ncl.2018.01.010","article-title":"Diagnosis of myasthenia gravis","volume":"36","author":"Pasnoor","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2020.108303_bib17","first-page":"815","article-title":"The Calabar bean as a new agent in ophthalmic practice","volume":"8","author":"Robertson","year":"1863","journal-title":"Edinb. Med. J."},{"key":"10.1016\/j.neuropharm.2020.108303_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ncl.2018.01.001","article-title":"Nature and action of antibodies in myasthenia gravis","volume":"36","author":"Ruff","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2020.108303_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/mi.10.1.1","article-title":"Episodes in the story of physostigmine","volume":"10","author":"Scheindlin","year":"2010","journal-title":"Mol. Interv."},{"key":"10.1016\/j.neuropharm.2020.108303_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM195408122510706","article-title":"Pyridostigmin (Mestinon) in the treatment of myasthenia gravis","volume":"251","author":"Schwab","year":"1954","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2020.108303_bib21","series-title":"Swaiman's Pediatric Neurology","first-page":"1098","article-title":"Acquired disorders of the neuromuscular junction","author":"Silvestri","year":"2018"},{"key":"10.1016\/j.neuropharm.2020.108303_bib22","first-page":"227","article-title":"Mestinon in myasthenia gravis (preliminary report)","volume":"15","author":"Tether","year":"1954","journal-title":"Dis. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2020.108303_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S0025727300030465","article-title":"The miracle at St. Alfege's","volume":"9","author":"Viets","year":"1954","journal-title":"Med. Hist."},{"key":"10.1016\/j.neuropharm.2020.108303_bib25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"1","author":"Walker","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2020.108303_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/003591573502800633","article-title":"Case showing the effect of prostigmin on myasthenia gravis","volume":"28","author":"Walker","year":"1935","journal-title":"Proc. Roy. Soc. Med."},{"key":"10.1016\/j.neuropharm.2020.108303_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.4.10.762","article-title":"Mestinon in the treatment of myasthenia gravis","volume":"4","author":"Westberg","year":"1954","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2020.108303_bib27","series-title":"Textbook of Ocular Pharmacology","first-page":"837","article-title":"Drugs for the diagnosis and treatment of myasthenia gravis","author":"Wolfe","year":"1997"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:09:01Z","timestamp":1758438541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"alternative-id":["S0028390820303713"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108303","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108303"}}